Biological Dynamics, Inc. v. Exokeryx, Inc.

CourtDistrict Court, S.D. California
DecidedApril 2, 2024
Docket3:23-cv-01664
StatusUnknown

This text of Biological Dynamics, Inc. v. Exokeryx, Inc. (Biological Dynamics, Inc. v. Exokeryx, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Biological Dynamics, Inc. v. Exokeryx, Inc., (S.D. Cal. 2024).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 Case No.: 23cv1664 DMS (JLB) BIOLOGICAL DYNAMICS, INC.,

11 Plaintiff, ORDER DENYING DEFENDANT’S 12 v. MOTION TO DISMISS 13 EXOKERYX, INC., 14 Defendant. 15 16 17 This case comes before the Court on Defendant’s motion to dismiss. Plaintiff filed 18 an opposition to the motion, and Defendant filed a reply. For the reasons set out below, 19 the motion is denied. 20 I. 21 BACKGROUND 22 Plaintiff Biological Dynamics is a “leader in exosome isolation technology.” 23 (Compl. ¶ 2.) According to the Complaint, 24 [e]xosomes and other extracellular vesicles are nonparticles secreted by all cell types into the blood or other biofluids. These nanoparticles carry 25 biomarkers of the cell from which they originated. Isolating exosomes and 26 extracellular vesicles allows researchers and professionals to then test for such biomarkers to determine disease characteristics and propensities. As 27 exosomes exist at an early stage of any disease, technology that can isolate 28 and test exosomes allows for the ‘holy grail’ – enabling early detection of 1 diseases (such as cancer) long before symptoms appear and at a time when treatment can be most effective. 2

3 (Id.) “A critical part of Biological Dynamics’ overall technology is its isolation platform— 4 sometimes referred to as a ‘lab-on-a-chip’ platform.” (Id. ¶ 3.) This platform “utilizes a 5 proprietary semiconductor chip that works in connection with Biological Dynamics’ 6 proprietary instruments, hardware, and software to isolate exosomes with minimum pre- 7 processing, thereby preserving biomolecules that would otherwise be lost in alternative 8 approaches.” (Id.) Biological Dynamics developed this platform “over more than a decade 9 and at immense expense[,]” and it “protects its investment and intellectual property through 10 both trade secrets and a large patent portfolio.” (Id. ¶ 4.) 11 Those trade secrets are the subject of this case. (Id.) Specifically, Plaintiff alleges 12 that two of its former VP-level employees, Richard Young and Bryan Rice, 13 misappropriated Plaintiff’s trade secrets after they were terminated from their employment 14 with Plaintiff. Armed with those trade secrets, Young and Rice formed Defendant 15 Exokeryx, which has “virtually replicated Biological Dynamics’ business by cloning 16 Biological Dynamics’ proprietary ‘lab-on-a-chip’ platform and core technology.” (Id. ¶ 17 6.) 18 Plaintiff alleges Defendant operated in “stealth” mode from its formation in 19 November 2021 until November 2022, and when it “exited ‘stealth’ mode” it “provided 20 data on experiments that it had run, indicated that it had already filed patent applications, 21 and announced that it would launch its first product ‘ExoPrep,’ in 2023.” (Id. ¶ 7.) Plaintiff 22 alleges Defendant 23 simply could not have developed such complicated technology, nor advanced its business, that quickly without the use of Biological Dynamics’ trade 24 secrets, including Biological Dynamics’ proprietary processes and 25 technologies. Others in this field indicate that the average time to market is over 15 years—a time horizon confirmed by the fact that it took Biological 26 Dynamics and its preeminent engineers and executives over a decade to 27 advance its development to its current commercial status.

28 1 (Id.) 2 To confirm its suspicions about Exokeryx, Plaintiff ran a forensic analysis of the 3 laptop that had been previously issued to and used by Rice during his employment with 4 Plaintiff. (Id. ¶ 8.) That analysis revealed that after Rice was terminated, “he connected a 5 USB ‘thumb’ drive to” the laptop, and “[b]etween 9 p.m. until after midnight, Rice 6 proceeded to copy critical Biological Dynamics’ documents onto it. Then, on the day Rice 7 agreed to appear at Biological Dynamics’ offices to surrender his Company laptop, Rice 8 spent the morning permanently deleting thousands of files from it.” (Id.) 9 After finding this information, Plaintiff sent a letter to Young and Rice reminding 10 them of their contractual obligations to maintain the confidentiality of Plaintiff’s trade 11 secrets and other proprietary information and to return any company-issued property. (Id. 12 ¶ 45.) When Plaintiff did not receive a satisfactory response to its letter, it filed an 13 arbitration demand against Young and Rice to enforce their contractual obligations under 14 their employment-related agreements. (Id.) During the arbitration proceedings, Young 15 and Rice challenged certain provisions of their employment-related contracts as 16 unenforceable restraints under California Business and Professions Code Section 16600. 17 (Id. ¶ 45 n.1.) The arbitrator ruled in favor of Young and Rice, and invalidated the 18 challenged provisions on nondisclosure and nonuse. (Id.) 19 On August 25, 2023, Rice and Young filed a petition to confirm the arbitrator’s 20 decision in San Diego Superior Court.1 Approximately two weeks after Rice and Young 21 filed that petition, Plaintiff filed the present case against Exokeryx alleging claims for 22 misappropriation of trade secrets under the Defend Trade Secrets Act (“DTSA”) and 23 California’s Uniform Trade Secrets Act (“CUTSA”). In response to the Complaint, 24 Defendant filed the present motion. 25 / / / 26

27 1 The state court recently issued an order confirming the arbitrator’s decision. (See Supp. 28 1 II. 2 DISCUSSION 3 Defendant moves to dismiss this case on two grounds. First, it argues the arbitration 4 decision and the state court order confirming that decision render this case res judicata. 5 Second, Defendant asserts Plaintiff has failed to allege sufficient facts to support the 6 element of misappropriation. 7 A. Res Judicata 8 An affirmative defense, such as res judicata, may be raised in a motion to dismiss 9 under Rule 12(b)(6) only when “the defense raises no disputed issues of fact,” Scott v. 10 Kuhlmann, 746 F.2d 1377, 1378 (9th Cir. 1984), and the affirmative defense “clearly 11 appears on the face of” the complaint. Boquist v. Courtney, 32 F.4th 764, 774 (9th Cir. 12 2022). On the first requirement, Defendant’s res judicata argument relies on the Complaint 13 in this case, Plaintiff’s complaints in arbitration, and the arbitrator’s final decision, all of 14 which are the proper subject of judicial notice.2 Defendant’s reliance on these documents 15 does not raise any disputed issues of fact, therefore the first requirement is met. The second 16 requirement is also met because the arbitration proceeding clearly appears on the face of 17 the Complaint. (Compl. ¶ 45.) 18

19 2 A court may consider “matters of judicial notice” in ruling on a motion to dismiss. United 20 States v. Ritchie, 342 F.3d 903, 908 (9th Cir. 2003). Here, Defendant asked the Court to 21 take judicial notice of the arbitration documents mentioned above and eight additional documents, including Rice and Young’s petition to confirm the arbitration award, 22 Plaintiff’s petition to vacate the arbitration award, discovery requests from the arbitration 23 proceedings, and Plaintiff’s Employee Handbook. (See Request for Judicial Notice in Supp. of Mot. (“RJN”), ECF No. 9-1.) Plaintiff filed a response to Defendant’s Request 24 for Judicial Notice in which it argued that although the Court could take judicial notice of 25 the fact of these documents, it could not take judicial notice of the documents’ contents. In its reply brief, Defendant clarified that, other than the allegations in the arbitration 26 complaints, it is not requesting that the Court take judicial notice of the contents of any of 27 these documents.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Iqbal v. Hasty
490 F.3d 143 (Second Circuit, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
W. Eugene Scott v. Edward L. Kuhlmann, Etc.
746 F.2d 1377 (Ninth Circuit, 1984)
Ronald Caldeira v. County of Kauai
866 F.2d 1175 (Ninth Circuit, 1989)
United States v. Bernice T. Morales
978 F.2d 650 (Eleventh Circuit, 1992)
Vella v. Hudgins
572 P.2d 28 (California Supreme Court, 1977)
Agarwal v. Johnson
603 P.2d 58 (California Supreme Court, 1979)
Federation of Hillside & Canyon Associations v. City of Los Angeles
24 Cal. Rptr. 3d 543 (California Court of Appeal, 2004)
Grundy v. Gourley
1 Cal. Rptr. 3d 104 (California Court of Appeal, 2003)
Johnson v. City of Loma Linda
5 P.3d 874 (California Supreme Court, 2000)
Boeken v. PHILIP MORRIS USA, INC.
230 P.3d 342 (California Supreme Court, 2010)
DKN Holdings LLC v. Faerber
352 P.3d 378 (California Supreme Court, 2015)
Patel v. Crown Diamonds, Inc. CA4/3
247 Cal. App. 4th 29 (California Court of Appeal, 2016)
Association of Irritated Residents v. Department of Conservation
11 Cal. App. 5th 1202 (California Court of Appeal, 2017)
Pearl Rangel v. Pls Check Cashers of Calif.
899 F.3d 1106 (Ninth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Biological Dynamics, Inc. v. Exokeryx, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/biological-dynamics-inc-v-exokeryx-inc-casd-2024.